BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36046199)

  • 1. Retrospective Cohort Analysis of Aspirin Use and Venous Thromboembolism in Patients with Pancreatic Cancer and an Indwelling Central Venous Catheter.
    King R; Schaefer J; Sahai V; Griffith KA; Sood SL
    TH Open; 2022 Jul; 6(3):e221-e229. PubMed ID: 36046199
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative thrombosis risk of vascular access devices among critically ill medical patients.
    White D; Woller SC; Stevens SM; Collingridge DS; Chopra V; Fontaine GV
    Thromb Res; 2018 Dec; 172():54-60. PubMed ID: 30384035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation for people with cancer and central venous catheters.
    Kahale LA; Tsolakian IG; Hakoum MB; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006468. PubMed ID: 29856471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis.
    Clark HH; Ballester L; Whitworth H; Raffini L; Witmer C
    Blood; 2022 Jan; 139(3):452-460. PubMed ID: 34727184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of aspirin to venous thromboembolism chemoprophylaxis safely decreases venous thromboembolism rates in trauma patients.
    Lammers D; Scerbo M; Davidson A; Pommerening M; Tomasek J; Wade CE; Cardenas J; Jansen J; Miller CC; Holcomb JB
    Trauma Surg Acute Care Open; 2023; 8(1):e001140. PubMed ID: 37936904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ALK Rearrangement on Venous and Arterial Thrombotic Risk in NSCLC.
    Al-Samkari H; Leiva O; Dagogo-Jack I; Shaw A; Lennerz J; Iafrate AJ; Bendapudi PK; Connors JM
    J Thorac Oncol; 2020 Sep; 15(9):1497-1506. PubMed ID: 32437899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapy use and the risk of venous thromboembolic events in the Raloxifene Use for the Heart (RUTH) trial.
    Duvernoy CS; Yeo AA; Wong M; Cox DA; Kim HM
    J Womens Health (Larchmt); 2010 Aug; 19(8):1459-65. PubMed ID: 20626269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Study on Efficacy and Safety of Rivaroxaban and Dalteparin for Long-Term Treatment of Venous Thromboembolism in Patients with Lung Cancer.
    Lee JH; Hyun DG; Choi CM; Lee JC; Kim WS; Oh YM; Lee SD; Lee JS
    Respiration; 2019; 98(3):203-211. PubMed ID: 31096241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Otten HM; Rutjes AW
    Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    Marik PE; Cavallazzi R
    PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.
    Cavallari I; Morrow DA; Creager MA; Olin J; Bhatt DL; Steg PG; Storey RF; Cohen M; Scirica BS; Piazza G; Goodrich EL; Braunwald E; Sabatine MS; Bonaca MP
    Circulation; 2018 Feb; 137(7):684-692. PubMed ID: 29084737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.
    Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
    Clin Orthop Relat Res; 2019 Feb; 477(2):396-402. PubMed ID: 30624322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
    Hess CN; Szarek M; Anand SS; Bauersachs RM; Patel MR; Debus ES; Nehler MR; Capell WH; Beckman JA; Piazza G; Henkin S; Bura-Rivière A; Lawall H; Roztocil K; Hsia J; Muehlhofer E; Berkowitz SD; Haskell LP; Bonaca MP
    JAMA Netw Open; 2022 Jun; 5(6):e2215580. PubMed ID: 35731517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
    Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis.
    Li A; Brandt W; Brown C; Wang TF; Ikesaka R; Delluc A; Wells P; Carrier M
    Thromb Res; 2021 Dec; 208():58-65. PubMed ID: 34715510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study.
    Huang H; Korn JR; Mallick R; Friedman M; Nichols C; Menzin J
    J Thromb Thrombolysis; 2012 Nov; 34(4):446-56. PubMed ID: 22581282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.